College of Contemporary Health

21/11/2025

Concerns about excessive screen time and mobile phone use are common among parents, and is often cited as a cause of declining among children and teenagers.

However, new research from the University of South Australia suggests that technology may also play a constructive role in helping young people adopt healthier behaviours.

This research represents the largest global analysis to date examining how affect health outcomes among people under the age of 18.

Drawing on data from more than 133,000 children and teenagers worldwide, the study indicates that mobile health applications, wearable devices and interactive digital programmes can support improvements in , dietary intake and weight-related outcomes.

A major global review shows digital tools can boost activity, improve diet, reduce sedentary time and support healthier weight in children and teenagers.

20/11/2025

UMass Chan Medical School has initiated a large research programme to examine whether a lifestyle change intervention can improve outcomes for people using therapies to manage , or cardiovascular disease.

This project marks the launch of the Implementation Research Network Collaborating Center at UMass Chan’s Prevention Research Center.

The centre is supported by a four-year, 2 million-dollar award from the United States Centers for Disease Control and Prevention.

UMass Chan Medical School has launched a CDC-funded collaborating centre to study how digital lifestyle interventions can support people using GLP-1 therapies for obesity, diabetes and cardiovascular disease. The four-year trial will evaluate Noom’s GLP-1 Companion, physical activity, diet, muscle...

19/11/2025

A new model capable of generating virtual patient representations and forecasting future health outcomes has been described as a potential breakthrough for clinical research.

The system, developed by researchers at The University of Melbourne, uses large language model ( ) techniques to create personalised that mirror each individual’s clinical profile.

Researchers believe the tool has significant implications for the future of clinical trials.

Because the model can simulate potential outcomes for large groups of virtual participants, it may help streamline drug development processes by reducing time and cost associated with early-stage testing.

A new AI tool creates digital twins of patients to forecast individual health trajectories with high accuracy. Researchers at the University of Melbourne report that the model outperforms leading machine learning systems and could accelerate clinical trials while supporting more predictive and perso...

18/11/2025

Researchers, clinicians and scientists at Stanford University have developed a model designed to improve prediction accuracy around donor viability.

The tool estimates whether a donor is likely to die within the period during which their organs remain suitable for transplantation.

The model surpassed the predictions of highly experienced surgeons and reduced the rate of futile procurements by 60%.

Futile procurements occur when surgical teams begin preparing for a but cannot proceed because the donor dies too late for the organ to remain viable.

A Stanford-developed AI tool predicts whether donor organs will remain viable within critical time limits, cutting futile transplant attempts by 60 percent and improving access for people awaiting transplants.

17/11/2025

Can you answer these three questions about AI in general practice?

→ Which AI tools actually save time versus adding work to your day?
→ How do you evaluate if an AI system meets NHS standards?
→ What happens to accountability when AI gets it wrong?

Most GPs can’t answer these confidently. Not because they’re unprepared, but because they’ve never been trained.

CCH have just launched 𝐀𝐈 𝐄𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥𝐬 𝐟𝐨𝐫 𝐆𝐏𝐬: 𝐓𝐨𝐨𝐥𝐬, 𝐄𝐭𝐡𝐢𝐜𝐬 𝐚𝐧𝐝 𝐄𝐯𝐞𝐫𝐲𝐝𝐚𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐢𝐭𝐨𝐧𝐬 - a CPD course that addresses exactly these questions.

Covers: AI tool evaluation, NHS standards, professional accountability, practical implementation.

Immediately applicable. 3.5 hours. £39.00 (launch price)

➡️ Course details here: https://www.contemporaryhealth.co.uk/ai-essentials-for-gps/

17/11/2025

A new report from the healthcare advisory firm Chartis suggests that and are now central pillars in health system leaders’ strategies to expand capacity, improve access, and operate more sustainably.

The findings come from the firm’s fifth annual survey, conducted in September 2025, which examined the perspectives of 150 system executives on their progress and priorities in transformation.

A new Chartis survey of 150 health system executives reveals that leaders are prioritising AI and digital health solutions to expand capacity, improve access, and shift towards proactive models of care. Findings highlight the growing importance of hospital-at-home services, digitally enabled referra...

14/11/2025

For many clinicians, the administrative workload associated with electronic health record ( ) systems extends well into the evening, contributing to frustration, diminished work satisfaction and widespread .

At Sutter Health in California, leaders have undertaken a substantial effort to determine whether augmented intelligence ( ) could help relieve this pressure and restore time and attention to patient care.

A recent pilot study, published in JAMA Network Open, involved physicians and non-physician providers across the organisation.

Participants reported spending less time on after-hours notes, feeling more present with patients during consultations and experiencing early signs of reduced .

Although limitations remain, the findings suggest that carefully implemented AI-supported documentation could contribute meaningfully to clinician well-being.

A Sutter Health study shows ambient AI reduced after-hours documentation, eased cognitive burden and helped 93% of clinicians give patients their “full attention”.

13/11/2025

A co-designed, digitally supported recovery pathway is helping people in regional access surgeon-approved post-operative without the need for long-distance travel.

The Panacea Pathway integrates predictive analytics and -generated insights to monitor progress, identify risks early, and support safer and more consistent recovery at home.

More than 3,000 at-home clinical appointments have been delivered, with patients reporting greater confidence, improved continuity of care, and fewer missed appointments.

A new AI-supported telehealth pathway is transforming hip replacement recovery for regional Australians by enabling safe, at-home monitoring and personalised care.

12/11/2025

People with (AFib) and may experience fewer episodes of irregular heart rhythm after undergoing ablation if they take the diabetes medication in addition to standard care, according to a preliminary presentation of late-breaking science at the American Heart Association’s (AHA) Scientific Sessions 2025, held from 7 to 10 November in New Orleans.

The annual meeting is a leading international forum for sharing new research and clinical advances in .

A new study presented at the American Heart Association’s 2025 Scientific Sessions found that metformin may help prevent atrial fibrillation recurrence after ablation in adults with obesity, suggesting potential cardiovascular benefits beyond diabetes management.

11/11/2025

Investigators at Weill Cornell Medicine have uncovered an early step in the chain of events that links to inflammation and insulin resistance – key contributors to the development of type 2 .

Their findings, published on 28 October in the The Journal of Clinical Investigation family of journals, identify a protein known as FAM20C as a critical “switch” that initiates within fat cells.

The study, conducted in mice, shows that when this protein is removed or blocked, improves markedly, even without weight loss.

Researchers at Weill Cornell Medicine have identified FAM20C, a protein that triggers inflammation and insulin resistance in fat cells. Blocking FAM20C improved metabolic health and insulin sensitivity in mice, revealing a promising new target for treating obesity-related type 2 diabetes.

10/11/2025

Researchers at Virginia Tech found that resistance training was more effective than running in improving glucose tolerance and reducing insulin resistance in mice fed a high-fat diet.

Both endurance and resistance reduced body fat and improved blood sugar regulation, but resistance training yielded stronger metabolic benefits.

The study suggests that strength training could play a particularly valuable role in preventing and managing Type 2 .

A new study from Virginia Tech shows that weightlifting is more effective than running in reducing fat, improving glucose tolerance, and lowering insulin resistance in a preclinical model of obesity and Type 2 diabetes.

06/11/2025

Novo Nordisk has presented new findings suggesting that its experimental oral medication delivers cardiovascular and metabolic benefits similar to those achieved with its blockbuster injectable, .

The results were shared at the ObesityWeek 2025 conference in and strengthen the Danish company’s case for approval of the pill in the United States later this year.

Novo Nordisk’s oral semaglutide 25 mg pill matches Wegovy injection for weight loss and cardiovascular benefits, new OASIS 4 data reveal.